FIELD: medicine.
SUBSTANCE: invention concerns a kit of reagents for pancreatic α-amylase activity test including a reagent 1 containing sodium chloride, potassium sulphocyanate, sodium azide, water-soluble calcium salt, monoclonal salivary α-amylase antibodies (MAB), 2-morpholinoethanesulfonic acid (MES) and water, and a reagent 2 containing 2-chloring-4-nitrophenyl-4-O-β-D-galactopyranosylmaltoside (GalG2CNP), MES and water, differing by the fact that the reagent 1 in addition contains EDTA and bovine serum albumin (BSA), and as calcium salt, it contains calcium acetate, and the reagent 2 in addition contains EDTA and sodium azide in the proportions specified in the patent claim.
EFFECT: enhanced stability of the set of reagents with maintaining high accuracy and result reproducibility of the analysis.
1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| REAGENT FOR TOTAL α-AMYLASE ACTIVITY TEST | 2009 |
|
RU2417374C1 |
| METHOD FOR DIAGNOSING CHRONIC PANCREATITIS CASES DEVELOPED ON THE BACKGROUND OF DUODENAL PEPTIC ULCER DISEASE | 2002 |
|
RU2249433C2 |
| DIAGNOSTIC TECHNIQUE FOR EARLY DISORDERS OF CARBOHYDRATE METABOLISM IN PATIENTS WITH CHRONIC PANCREATITIS | 2023 |
|
RU2824803C1 |
| SOLUTION FOR BICARBONATE HEMODIALISYS | 2012 |
|
RU2521361C2 |
| CROSS-LINKED LIPASE CRYSTALS, COMPOSITION BASED THEREON AND METHOD FOR MAKING THEREOF | 1998 |
|
RU2380415C2 |
| DIAGNOSTIC PLATE FOR DETERMINATION OF UREA CONCENTRATIONS | 2018 |
|
RU2710268C2 |
| STABILIZING MEDIUM FOR α-GST IN URINE AND METHOD FOR DETERMINING QUANTITY OF α-GST IN URINE | 1994 |
|
RU2142136C1 |
| CROSS-LINKED PROTEIN CRYSTAL WITH CONTROLLED DISSOLVING | 1998 |
|
RU2241746C2 |
| RADIOACTIVE LABELING SET AND BINDING ANALYSIS | 2000 |
|
RU2251110C2 |
| METHOD FOR PREPARING COLLAGENASE | 2003 |
|
RU2236460C1 |
